Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 14101 - 14125 of 14985 in total
ORP-101 is under investigation in clinical trial NCT04129619 (A Comparison of the Effects of ORP-101 Versus Placebo in Adult Patients With Irritable Bowel Syndrome With Diarrhea (IBS-D)).
Investigational
Matched Description: … ORP-101 is under investigation in clinical trial NCT04129619 (A Comparison of the Effects of ORP-101 …
An ester of beclomethasone.
Experimental
Matched Description: … An ester of beclomethasone. …
Zanapezil (TAK-147) is a selective acetylcholine (ACh) esterase inhibitor under investigation as a drug for Alzheimer's disease (AD) treatment.
Investigational
HMR4011 (IPL 576,092) is a novel steroidal anti-inflammatory compound with a mechanism of action distinct from that of glucocorticoid. IPL 576,092 has previously been investigated as a treatment for asthma.
Investigational
Matched Description: … from that of glucocorticoid. ... HMR4011 (IPL 576,092) is a novel steroidal anti-inflammatory compound with a mechanism of action distinct …
MB07133 is a HepDirect prodrug of an activated form of cytarabine (araC), an anti-cancer drug that is used to treat leukemia but is ineffective against primary liver cancer. AraC's anti-cancer activity is associated with its ability to be converted to its biologically active form, araCTP. However, araC is only slowly...
Investigational
Matched Description: … MB07133 is a HepDirect prodrug of an activated form of cytarabine (araC), an anti-cancer drug that is ... activation pathway of the drug. ... , araC is only slowly converted to araCTP in the liver or in primary liver tumors due to low levels of
2-(5-fluoro-pentyl)-2-methyl-malonic-acid is under investigation in clinical trial NCT00696943 (18F ML-10 for Early Detection of Response of Brain Metastases to SRS).
Investigational
Matched Description: … Response of Brain Metastases to SRS). ... methyl-malonic-acid is under investigation in clinical trial NCT00696943 (18F ML-10 for Early Detection of
Experimental
LY518674 has been used in trials studying the treatment of Metabolic Syndrome X.
Investigational
Matched Description: … LY518674 has been used in trials studying the treatment of Metabolic Syndrome X. …
Experimental
PF-06751979 is under investigation in clinical trial NCT03126721 (The Study is to Evaluate the Effect of Multiple Doses PF-06751979 on the Pharmacokinetics of Midazolam in Healthy Adults).
Investigational
Matched Description: … Multiple Doses PF-06751979 on the Pharmacokinetics of Midazolam in Healthy Adults). ... -06751979 is under investigation in clinical trial NCT03126721 (The Study is to Evaluate the Effect of
Experimental
Rabeximod is an orally administered compound for treatment of moderate or severe active rheumatoid arthritis that is currently undergoing phase II clinical testing in eight European countries.
Investigational
Matched Description: … Rabeximod is an orally administered compound for treatment of moderate or severe active rheumatoid arthritis …
Displaying drugs 14101 - 14125 of 14985 in total